TEZSPIRE
- Product NDC
- 55513-100
- Requested package NDC
- 55513-100-96
- 11-digit product format
- 555130100
- Labeler code
- 55513
- Product ID
- 55513-100_25a4a901-927c-4f3a-a1c4-72826d46e946
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tezepelumab-ekko
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Amgen, Inc
- Application
- BLA761224
- Marketing category
- BLA
- Marketing start
- 2021-12-17
- Marketing end
- 0000-00-00
- Substance
- TEZEPELUMAB
- Active strength
- 210 mg/1.9mL
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 55513-100 | 55513-100-96 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 55513-100 | 55513-100-96 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 55513-100 | 55513-100-96 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dcda8adb-29c0-4f01-aff6-2e9233ef700d | Product name | 1 | 20220720 |
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55513-100-01 | TEZSPIRE | 1.91 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 1.91 | 15 | |
| 55513-100-01 | TEZSPIRE | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 15 | |
| 55513-100-96 | TEZSPIRE | 1.91 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 1.91 | 15 | |
| 55513-100-96 | TEZSPIRE | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 15 | |
| 55513-100-99 | TEZSPIRE | 1.91 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 1.91 | 15 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TEZSPIRE | TEZEPELUMAB-EKKO | Amgen Inc | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 2025-10-17 | Warnings, Adverse reactions | BLA761224 55513-100-96 55513-100 55513010096 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761224 | Tezspire | tezepelumab-ekko | 351(a) | Rx | 2026-09-01 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2628920 | tezepelumab-ekko 210 MG in 1.91 ML Auto-Injector | PSN | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587794 | tezepelumab-ekko 210 MG in 1.91 ML Injection | PSN | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587803 | tezepelumab-ekko 210 MG in 1.91 ML Prefilled Syringe | PSN | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2628923 | Tezspire 210 MG in 1.91 ML Auto-Injector | PSN | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587800 | Tezspire 210 MG in 1.91 ML Injection | PSN | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587806 | Tezspire 210 MG in 1.91 ML Prefilled Syringe | PSN | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2628923 | 1.91 ML tezepelumab-ekko 110 MG/ML Auto-Injector [Tezspire] | SBD | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587800 | 1.91 ML tezepelumab-ekko 110 MG/ML Injection [Tezspire] | SBD | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587806 | 1.91 ML tezepelumab-ekko 110 MG/ML Prefilled Syringe [Tezspire] | SBD | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2628920 | 1.91 ML tezepelumab-ekko 110 MG/ML Auto-Injector | SCD | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587794 | 1.91 ML tezepelumab-ekko 110 MG/ML Injection | SCD | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587803 | 1.91 ML tezepelumab-ekko 110 MG/ML Prefilled Syringe | SCD | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2628923 | 1.91 ML Tezspire 110 MG/ML Auto-Injector | SY | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587800 | 1.91 ML Tezspire 110 MG/ML Injection | SY | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587806 | 1.91 ML Tezspire 110 MG/ML Prefilled Syringe | SY | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2628920 | tezepelumab-ekko 210 MG per 1.91 ML Auto-Injector | SY | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587794 | tezepelumab-ekko 210 MG per 1.91 ML Injection | SY | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587803 | tezepelumab-ekko 210 MG per 1.91 ML Prefilled Syringe | SY | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2628923 | Tezspire 210 MG per 1.91 ML Auto-Injector | SY | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587800 | Tezspire 210 MG per 1.91 ML Injection | SY | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
| 2587806 | Tezspire 210 MG per 1.91 ML Prefilled Syringe | SY | 60f0aa03-ad25-4d48-80ce-7fcfa76f325f | 15 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 55513-100-96 | 55513010096 | 1 VIAL, GLASS in 1 CARTON (55513-100-96) > 1.91 mL in 1 VIAL, GLASS | 2021-12-17 | 0000-00-00 | Yes | No | Current |